Results 71 to 80 of about 64,948 (193)
Treatment of Atrophic Acne Scars with Platelet Rich Plasma Gel and Micro-needling [PDF]
Background: Following the advancements in the treatment of acne, post-acne scarring is still a widespread problem. Platelet-rich plasma (PRP) gel is one formulation with beneficial biological or medicinal qualities that aid in the management of post-acne
Shafik, Enas Tarek +4 more
core
Cosmetic Dermatology in Pregnancy and Lactation: A Risk–Benefit Framework for Clinical Practice
Summary of the safety profile of common cosmetic dermatology interventions during pregnancy and lactation. ABSTRACT Cosmetic dermatologic products and procedures are increasingly utilized by women of reproductive age, including those who are pregnant or lactating.
Timea Kovacs +6 more
wiley +1 more source
The Use of a Fractional Laser in Acne Scar Treatment—A Systematic Review
Background/Objectives: Acne scars are an unwanted reminder of past acne. They constitute a significant esthetic and psychosocial problem, negatively affecting the quality of life of patients. There are many methods used to treat acne scars.
Bartłomiej Ptaszek +2 more
doaj +1 more source
Proposal for post-acne scar management algorithm.
A review of the thearies available in treating post-acne scars is performed and a treatment algorithm is ...
Bettoli V +6 more
core
Graphical abstract summarizing evidence that dissecting cellulitis of the scalp (DC) and hidradenitis suppurativa (HS) may represent site‐modified expressions of a shared follicular‐occlusion pathway, highlighting convergent clinical, histopathologic, and therapeutic features, the diagnostic‐context paradox, and the need for paired molecular studies ...
Giuseppe Gallo +6 more
wiley +1 more source
Acne scarring is a common problem that affects significant number of acne patients. Currently there is no standart treatment for acne scars, and often several modalities may be combined to achieve best results.
Tatlıparmak, Aslı
core
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis +54 more
wiley +1 more source
Acne scars represent a real challenge to the dermatologist: several histological and macroscopical distinctive features require different therapeutic approaches. Among the several available classification, Goodman et al.
FABBROCINI, GABRIELLA
core
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Suzan Al‐Gburi +17 more
wiley +1 more source
A matching‐adjusted indirect treatment comparison (MAIC) was conducted, comparing approved biologics for long‐term (48–52 weeks) treatment of moderate‐to‐severe hidradenitis suppurativa (HS). Using weighted patient‐level trial data allowed re‐estimation of relative bimekizumab efficacy compared with aggregate secukinumab and adalimumab trial data ...
Thrasyvoulos Tzellos +9 more
wiley +1 more source

